Home › Stocks › ELOX › Changes

Who bought & sold ELOX (Q2 2026)

Funds holding (Q2 2026)22
New positions22
Added0
Reduced0
Exited0

As of Q2 2026, 22 institutional funds reported holding ELOX (ELOXX PHARMACEUTICALS INC): 22 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (20 of 22)

Fund Shares Value Weight
Aberdeen Group plc New 400.00K $5.55M 0.0
EcoR1 Capital, LLC New 400.00K $5.55M 0.3
Nantahala Capital Management, LLC New 400.00K $5.55M 0.2
Samsara BioCapital, LLC New 400.00K $5.55M 0.5
Siren, L.L.C. New 400.00K $5.55M 0.1
Stonepine Capital Management, LLC New 397.16K $5.51M 3.6
VANGUARD CAPITAL MANAGEMENT LLC New 78.68K $1.09M —
VANGUARD FIDUCIARY TRUST CO New 10.60K $147.16K —
SEVEN GRAND MANAGERS, LLC New 10.00K $138.80K 0.0
Morgan Stanley New 1.54K $21.43K —
Vanguard Global Advisers, LLC New 718 $9.97K —
UBS Group AG New 637 $8.84K —
Wells Fargo & Co New 126 $1.75K —
Pioneer Family Office, LLC New 96 $1.33K 0.0
ROYAL BANK OF CANADA New 98 $1.00K —
Altshuler Shaham Ltd New 25 $347 —
BARCLAYS PLC New 12 $167 —
Towne Trust Company, N.A New 5 $69 —
Activest Wealth Management New 4 $56 —
Citigroup Inc New 4 $56 —

Added to positions (0)

No adds this quarter.

Reduced positions (0)

No trims this quarter.

Exited positions (0)

No exits this quarter.